Illumina Inc
ILMN Real Time Price USDRecent trades of ILMN by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in ILMN holdings by institutional investors
Quarterly net insider trading by ILMN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$320,000 Apr 20, 2026 Issue: Budget/Appropriations Health Issues Homeland Security Medicare/Medicaid Trade (domestic/foreign)
-
$330,000 Jan 20, 2026 Issue: None
-
$380,000 Oct 20, 2025 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$410,000 Jul 21, 2025 Issue: Budget/Appropriations Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$620,000 May 08, 2025 Issue: Budget/Appropriations Health Issues Homeland Security
-
$400,000 Jan 21, 2025 Issue: Budget/Appropriations Health Issues Defense
-
$280,000 Dec 12, 2024 Issue: Budget/Appropriations Defense Health Issues
-
$270,000 Jul 22, 2024 Issue: Defense Trade (domestic/foreign) Health Issues
-
$510,000 Jan 22, 2024 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
-
$420,000 Oct 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
-
$1,460,000 Jul 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
-
$1,300,000 Jan 20, 2023 Issue: Trade (domestic/foreign) Government Issues Health Issues
-
$1,380,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
-
$1,690,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
-
$1,960,000 Apr 20, 2022 Issue: Government Issues Health Issues
-
$820,000 Jan 20, 2022 Issue: Government Issues
-
$10,000 Jan 20, 2022 Issue: Government Issues
-
$60,000 Jan 20, 2022 Issue: Health Issues
-
$50,000 Jan 20, 2022 Issue: None
-
$40,000 Jan 20, 2022 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
-
$50,000 Jan 20, 2022 Issue: Health Issues
-
$60,000 Jan 19, 2022 Issue: Health Issues
-
$320,000 Jan 19, 2022 Issue: Health Issues Government Issues
-
$10,000 Oct 28, 2021 Issue: Government Issues
-
$920,000 Oct 21, 2021 Issue: Government Issues
-
$60,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Oct 20, 2021 Issue: None
-
$40,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
-
$10,000 Oct 19, 2021 Issue: Government Issues
-
$50,000 Oct 19, 2021 Issue: Health Issues
-
$375,000 Oct 18, 2021 Issue: Health Issues Government Issues
-
$20,000 Jul 29, 2021 Issue: Health Issues
-
$60,000 Jul 20, 2021 Issue: Health Issues Labor Issues/Antitrust/Workplace
-
$40,000 Jul 20, 2021 Issue: Labor Issues/Antitrust/Workplace Health Issues Veterans Medicare/Medicaid
-
$40,000 Jul 20, 2021 Issue: Government Issues
-
$150,000 Jul 19, 2021 Issue: Health Issues Government Issues
-
$50,000 Jul 19, 2021 Issue: Trade (domestic/foreign)
-
$290,000 Apr 20, 2021 Issue: None
-
$270,000 Jan 21, 2021 Issue: None
-
$270,000 Oct 20, 2020 Issue: None
-
$170,000 Jul 20, 2020 Issue: None
-
$180,000 Apr 20, 2020 Issue: HEALTH ISSUES
-
$190,000 Jan 21, 2020 Issue: None
-
$160,000 Oct 21, 2019 Issue: Budget/Appropriations Health Issues
-
$160,000 Jul 22, 2019 Issue: Budget/Appropriations Health Issues
-
$130,000 Apr 22, 2019 Issue: Health Issues Budget/Appropriations
-
$60,000 Jan 22, 2019 Issue: Health Issues
-
$60,000 Oct 22, 2018 Issue: Health Issues
-
$70,000 Jul 20, 2018 Issue: Health Issues
-
$100,000 Apr 20, 2018 Issue: Medicare/Medicaid Budget/Appropriations
-
$50,000 Jan 19, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
-
$50,000 Oct 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
-
$50,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid
-
$40,000 Apr 18, 2017 Issue: Medical/Disease Research/Clinical Labs
-
$45,000 Jan 13, 2017 Issue: Health Issues
-
$45,000 Oct 19, 2016 Issue: Health Issues
-
$60,000 Jul 20, 2016 Issue: Health Issues
-
$90,000 Apr 20, 2016 Issue: Health Issues
-
$20,000 Jan 20, 2016 Issue: Health Issues
-
$40,000 Jan 18, 2013 Issue: Homeland Security Science/Technology Defense
ILMN Estimated quarterly lobbying spending
ILMN Revenue by Segment or Geography
New ILMN patent grants
-
Patent Title: Methods for producing stranded cdna libraries Feb. 09, 2016
-
Patent Title: Oligonucleotide replacement for di-tagged and directional libraries Jan. 19, 2016
-
Patent Title: Molecule detection system on a solid support Dec. 29, 2015
-
Patent Title: Systems for and methods of facilitating focusing an optical scanner Dec. 01, 2015
-
Patent Title: Expanded radix for polymeric tags Dec. 01, 2015
-
Patent Title: Methods and systems for controlling liquids in multiplex assays Nov. 24, 2015
-
Patent Title: Sequencing by orthogonal synthesis Nov. 24, 2015
-
Patent Title: Super resolution imaging Nov. 24, 2015
-
Patent Title: Integrated optoelectronic read head and fluidic cartridge useful for nucleic acid sequencing Nov. 24, 2015
-
Patent Title: Hla typing using selective amplification and sequencing Nov. 10, 2015
-
Patent Title: Kinetic exclusion amplification of nucleic acid libraries Oct. 27, 2015
-
Patent Title: Combinatorial decoding of random nucleic acid arrays Oct. 20, 2015
-
Patent Title: Nucleotides and primers with removable blocking groups Oct. 06, 2015
-
Patent Title: Assay instrument for detecting optical signals from samples having a controlled optics adjustment system based on the priority statuses of the samples Sep. 22, 2015
-
Patent Title: Compositions and methods for representational selection of nucleic acids from complex mixtures using hybridization Sep. 22, 2015
-
Patent Title: Independently removable nucleic acid sequencing system and method Sep. 01, 2015
-
Patent Title: Sequence scheduling and sample distribution techniques Aug. 25, 2015
-
Patent Title: Method for nucleotide detection Aug. 25, 2015
-
Patent Title: Microdevices and biosensor cartridges for biological or chemical analysis and systems and methods for the same Aug. 04, 2015
-
Patent Title: Linking sequence reads using paired code tags Jul. 07, 2015
-
Patent Title: Methods and compositions for processing chemical reactions Jul. 07, 2015
-
Patent Title: Compensator for multiple surface imaging Jun. 30, 2015
-
Patent Title: Compositions and methods for nucleotide sequencing Jun. 09, 2015
-
Patent Title: Methods and compositions for whole genome amplification and genotyping Jun. 02, 2015
-
Patent Title: Functionalization and purification of molecules by reversible group exchange May. 26, 2015
-
Patent Title: Microvessels, microparticles, and methods of manufacturing and using the same May. 05, 2015
-
Patent Title: Polymer coatings Apr. 21, 2015
-
Patent Title: Multibase delivery for long reads in sequencing by synthesis protocols Apr. 14, 2015
-
Patent Title: Methods for selecting and amplifying polynucleotides Apr. 07, 2015
-
Patent Title: Method of nucleic acid amplification Mar. 31, 2015
-
Patent Title: Methods for sequencing polynucleotides Mar. 10, 2015
-
Patent Title: Method and system for determining the accuracy of dna base identifications Feb. 24, 2015
-
Patent Title: Data processing system and methods Feb. 24, 2015
-
Patent Title: Solid-phase clonal amplification and related methods Feb. 10, 2015
-
Patent Title: Systems, methods, and apparatuses to image a sample for biological or chemical analysis Feb. 10, 2015
-
Patent Title: Method for retaining even coverage of short insert libraries Jan. 13, 2015
-
Patent Title: Devices and systems for creation of dna cluster arrays Dec. 30, 2014
-
Patent Title: Compositions and methods for representational selection of nucleic acids from complex mixtures using hybridization Dec. 23, 2014
-
Patent Title: Nucleic acid sequencing system and method Dec. 16, 2014
-
Patent Title: Methods of forming and using a solid-phase support Dec. 16, 2014
-
Patent Title: Multiplex nucleic acid reactions Dec. 09, 2014
-
Patent Title: Biosensors for biological or chemical analysis and systems and methods for same Dec. 09, 2014
-
Patent Title: Preservation of information related to genomic dna methylation Nov. 25, 2014
-
Patent Title: Kinetic exclusion amplification of nucleic acid libraries Nov. 25, 2014
-
Patent Title: Confocal imaging methods and apparatus Nov. 11, 2014
-
Patent Title: Formylpyrrole-based heterocycles for nucleic acid attachment to supports Nov. 11, 2014
-
Patent Title: Use of microfluidic systems in the detection of target analytes using microsphere arrays Nov. 11, 2014
-
Patent Title: Systems for and methods of facilitating focusing an optical scanner Oct. 21, 2014
-
Patent Title: Linking sequence reads using paired code tags Sep. 09, 2014
-
Patent Title: Compositions and methods for nucleotide sequencing Aug. 19, 2014
Federal grants, loans, and purchases
- $39,168 2026-07-09 00:00:00 Agency: Department of Agriculture
- $16,760 2026-07-09 00:00:00 Agency: National Aeronautics and Space Administration
- $143,975 2026-07-08 00:00:00 Agency: Department of Health and Human Services
- $99,994 2026-07-08 00:00:00 Agency: Department of Health and Human Services
- $250,498 2026-07-07 00:00:00 Agency: Department of Health and Human Services
- $24,031 2026-07-07 00:00:00 Agency: Department of Health and Human Services
- $26,738 2026-06-30 00:00:00 Agency: Department of Health and Human Services
- $411,752 2026-06-26 00:00:00 Agency: Department of Agriculture
- $53,443 2026-06-25 00:00:00 Agency: Department of Health and Human Services
- $104,060 2026-06-25 00:00:00 Agency: Department of the Interior
- $29,394 2026-06-23 00:00:00 Agency: Department of Health and Human Services
- $12,525 2026-06-23 00:00:00 Agency: Department of Health and Human Services
- $55,984 2026-06-22 00:00:00 Agency: Department of Commerce
- $24,224 2026-06-20 00:00:00 Agency: Department of Health and Human Services
- $116,928 2026-06-18 00:00:00 Agency: Department of Health and Human Services
- $113,604 2026-06-18 00:00:00 Agency: Department of Agriculture
- $22,665 2026-06-18 00:00:00 Agency: Department of Health and Human Services
- $128,813 2026-06-16 00:00:00 Agency: Department of the Interior
- $23,750 2026-06-16 00:00:00 Agency: Environmental Protection Agency
- $50,522 2026-06-16 00:00:00 Agency: Department of Health and Human Services
- $313,463 2026-06-16 00:00:00 Agency: Department of Health and Human Services
- $100,560 2026-06-15 00:00:00 Agency: Department of Health and Human Services
- $142,811 2026-06-15 00:00:00 Agency: Department of Health and Human Services
- $45,683 2026-06-10 00:00:00 Agency: Department of Agriculture
- $31,461 2026-06-10 00:00:00 Agency: Department of Health and Human Services
- $58,821 2026-06-09 00:00:00 Agency: Department of Health and Human Services
- $30,998 2026-06-09 00:00:00 Agency: Department of Agriculture
- $15,810 2026-06-08 00:00:00 Agency: Department of Agriculture
- $9,233 2026-06-05 00:00:00 Agency: Department of Commerce
- $29,572 2026-06-04 00:00:00 Agency: Department of the Interior
- $23,443 2026-06-03 00:00:00 Agency: Department of Health and Human Services
- $90,847 2026-06-03 00:00:00 Agency: Department of Health and Human Services
- $160,371 2026-05-28 00:00:00 Agency: Department of Health and Human Services
- $13,126 2026-05-27 00:00:00 Agency: Department of the Interior
- $208,735 2026-05-27 00:00:00 Agency: Department of Health and Human Services
- $48,209 2026-05-26 00:00:00 Agency: Department of Health and Human Services
- $111,116 2026-05-26 00:00:00 Agency: Department of Health and Human Services
- $25,959 2026-05-22 00:00:00 Agency: Department of Health and Human Services
- $0 2026-05-22 00:00:00 Agency: Department of Health and Human Services
- $119,363 2026-05-21 00:00:00 Agency: National Aeronautics and Space Administration
- $33,721 2026-05-21 00:00:00 Agency: Department of Health and Human Services
- $46,737 2026-05-20 00:00:00 Agency: Department of Health and Human Services
- $26,225 2026-05-20 00:00:00 Agency: Department of Health and Human Services
- $98,922 2026-05-20 00:00:00 Agency: Department of Agriculture
- $17,452 2026-05-13 00:00:00 Agency: Department of the Interior
- $52,603 2026-05-12 00:00:00 Agency: Department of Health and Human Services
- $21,843 2026-05-12 00:00:00 Agency: Department of Agriculture
- $92,585 2026-05-11 00:00:00 Agency: Department of Health and Human Services
- $48,209 2026-05-07 00:00:00 Agency: Department of Health and Human Services
- $16,068 2026-05-07 00:00:00 Agency: Department of Agriculture
Estimated quarterly amount awarded to ILMN from public contracts
Recent insights relating to ILMN
Recent picks made for ILMN stock on CNBC
ETFs with the largest estimated holdings in ILMN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ILMN stock a Buy, Sell, or Hold?
- What is the price target for $ILMN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ILMN stock?
- Who owns the most shares of $ILMN stock?
- What funds own $ILMN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ILMN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
- Address San Diego, CA
- Market Cap 28.3 billion
- Employees 8,650
- Industrial Classification Laboratory Analytical Instruments
We estimate that -- received a compensation of -- in --, making them the highest paid executive at ILMN, per a recent SEC DEF 14A filing. We estimate that the median employee at ILLUMINA, INC. is paid $138,432.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|